3AM-27722-63950
4 vaccinations
5 coded responses
52 check-ins
5 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 352 / AL
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-01
Registered in v-safe
-
2021-02-01
Dose 1 — Moderna
- 2021-02-01
-
2021-02-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
-
2021-03-04
Dose 2 — Moderna
-
2021-03-04
Survey response — day 0, dose 2MedDRA: Lacrimation increased, Rhinorrhoea — Feeling: Good · Site: PainFree text: Runny nose and eyesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-06-03
- 2021-09-02
-
2021-11-05
Dose 3 — Moderna
-
2021-11-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Swollen Lymph NodeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Swollen axillary lymph nodeMedDRA releases: 2024-11 · check-in free text available
-
2021-11-09
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Swollen lymph nodeMedDRA releases: 2024-11 · check-in free text available
- 2021-11-10
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2022-02-04
- 2022-05-06
-
2022-10-28
Dose 4 — Moderna
-
2022-10-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-10-30
- 2022-10-31
- 2022-11-01
- 2022-11-02
-
2022-11-03
Health check-in — days 1–6 daily, dose 4Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-11-04
- 2022-11-11
-
2022-11-18
Survey response — day 21, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend schoolFree text: COVID diagnosisMedDRA releases: 2024-11 · check-in free text available
- 2022-11-25
- 2022-12-02
- 2022-12-09
- 2023-01-27
- 2023-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Moderna | |
| 2 | 2021-03-04 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
| 4 | 2022-10-28 | Moderna | No |
Free text
Release 5 — day 0, dose 2
Systemic reaction (other): Runny nose and eyes
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen Lymph Node
Systemic reaction (other): Swollen axillary lymph node
Systemic reaction (other): Swollen lymph node
Release 12 — day 21, dose 4
Symptoms: COVID diagnosis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Lacrimation increased | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release